查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1610206

器官移植诊断市场：按产品、技术和应用分类 - 2025-2030 年全球预测

Organ Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Technologies, Non-Molecular Technologies), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年器官移植诊断市值为42亿美元，预计2024年将达到44.6亿美元，复合年增长率为7.31%，到2030年将达到68.9亿美元。

器官移植诊断市场包括诊断工具和测试的开发，以评估供体-受体的兼容性、监测移植健康状况以及检测可能的移植后排斥或感染疾病。这些诊断的需求源于确保器官移植成功、尽量减少併发症和延长移植物存活的迫切需求。主要应用包括移植前适宜性检查、移植后监测和感染筛检，最终用途包括医院、移植中心和诊断实验室。该市场的成长要素包括分子诊断的进步、导致器官衰竭的慢性疾病的流行以及器官移植手术的增加。此外，基因组学和蛋白​​质组学的技术创新正在实现更准确、更全面的诊断解决方案，扩大潜在的商机。利用这些机会的建议包括投资次世代定序技术的研究和开发以及扩大诊断组合以包括非侵入性检测方法。然而，仍存在一些限制因素，例如诊断测试成本上升、低收入地区的准入有限以及阻碍产品核可的严格监管框架。应对这些挑战需要策略联盟、创新以降低成本以及倡导有利政策以提高市场渗透率。潜在的创新领域包括开发自动化诊断平台、预测长期移植结果的生物标记以及用于个人化移植医学的人工智慧主导的资料分析工具。在持续的科学研究和技术进步的推动下，市场动态是充满活力和竞争的。公司可以透过专注于与医疗机构的合作、扩展到医疗需求未满足的新兴市场以及保持敏捷性以适应监管变化而受益。透过专注于这些策略，相关人员可以增强其市场地位，并为改善全球移植诊断做出贡献。

主要市场统计
基准年[2023] 42亿美元
预测年份 [2024] 44.6亿美元
预测年份 [2030] 68.9亿美元
复合年增长率（%） 7.31%

市场动态：快速发展的器官移植诊断市场的关键市场洞察

供需的动态交互作用正在改变器官移植诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 肝功能衰竭、肾衰竭和心臟衰竭的发生率增加
    • 政府推动器官捐赠的努力
    • 精准医学的兴起改善器官移植诊断
  • 市场限制因素
    • 与诊断相关的技术限制
  • 市场机会
    • 开发下一代器官移植诊断学的研究与开发
    • 医疗旅游在器官移植的潜力
  • 市场挑战
    • 器官移植相关的伦理问题

波特五力：驾驭器官移植诊断市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解器官移植诊断市场的外部影响

外部宏观环境因素在塑造器官移植诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解器官移植诊断市场的竞争状况

器官移植诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵器官移植诊断市场供应商绩效评估

FPNV定位矩阵是评估器官移植诊断市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製器官移植诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对器官移植诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肝、肾和心臟衰竭的发生率增加
      • 政府推动器官捐赠的努力
      • 精准医学的兴起改善器官移植诊断
    • 抑制因素
      • 与诊断相关的技术限制
    • 机会
      • 促进下一代发展的器官移植诊断学的研究与开发
      • 医疗旅游在器官移植的潜力
    • 任务
      • 器官移植相关的伦理问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 器官移植诊断市场：依报价

  • 装置
  • 试剂/耗材
  • 软体和服务

第七章器官移植诊断市场：依技术分类

  • 分子技术
  • 非分子技术

第八章器官移植诊断市场：依应用分类

  • 诊断应用
  • 调查申请

第九章北美及南美器官移植诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区器官移植诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲器官移植诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • BAG Diagnostics GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenuix Medsystems Pvt. Ltd
  • BioMAdvanced Diagnostics
  • Biomerieux SA.
  • Bruker Corporation
  • CareDx Inc.
  • F Hoffman La Roche Ltd.
  • GenDx by Eurobio Scientific
  • Genome Diagnostics BV
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Omixon Ltd.
  • Oncocyte Corporation
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • SQI Diagnostics
  • Thermo Fisher Scientific Inc.
  • TransMedics, Inc.
  • Werfen
Product Code: MRR-5C6F41F5B031

The Organ Transplant Diagnostics Market was valued at USD 4.20 billion in 2023, expected to reach USD 4.46 billion in 2024, and is projected to grow at a CAGR of 7.31%, to USD 6.89 billion by 2030.

The organ transplant diagnostics market involves the development and application of diagnostic tools and tests to assess the compatibility of donors and recipients, monitor transplant health, and detect potential rejections or infections post-transplantation. The necessity for these diagnostics arises from the critical need to ensure successful organ transplantation outcomes, minimize complications, and prolong graft survival. The main application areas include pre-transplant compatibility testing, post-transplant monitoring, and infection screening, with significant end-use scope encompassing hospitals, transplant centers, and diagnostic laboratories. Influencing growth factors for this market include advancements in molecular diagnostics, increased prevalence of chronic diseases leading to organ failure, and a rise in organ transplant procedures. Additionally, technological innovations in genomics and proteomics are opening potential opportunities by enabling more precise and comprehensive diagnostic solutions. Recommendations to leverage these opportunities include investing in R&D for next-generation sequencing technologies and expanding diagnostic portfolios to include non-invasive testing methods. However, the market also faces limitations such as high costs of diagnostic tests, limited accessibility in low-income regions, and stringent regulatory frameworks that can impede swift product approvals. Addressing these challenges requires strategic collaborations, cost-reduction innovations, and advocacy for favorable policies to improve market penetration. Potential areas for innovation include the development of automated diagnostic platforms, biomarkers for predicting long-term transplant outcomes, and AI-driven data analysis tools for personalized transplant care. The nature of the organ transplant diagnostics market is dynamic and highly competitive, driven by continuous scientific research and technological advancements. Companies can benefit from focusing on collaborative efforts with healthcare institutions, expanding into emerging markets with unmet medical needs, and maintaining agility in adapting to regulatory changes. By emphasizing these strategies, stakeholders can enhance their market position and contribute to improved transplant diagnostic practices globally.

KEY MARKET STATISTICS
Base Year [2023] USD 4.20 billion
Estimated Year [2024] USD 4.46 billion
Forecast Year [2030] USD 6.89 billion
CAGR (%) 7.31%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplant Diagnostics Market

The Organ Transplant Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of liver, kidney, and heart failure
    • Government initiatives in promoting organ donation
    • Rise of precision medicine to improve organ transplant diagnostics
  • Market Restraints
    • Technical limitations associated with diagnostics
  • Market Opportunities
    • R&D to develop next generation organ transplant diagnostics
    • Potential of medical tourism in organ transplantation
  • Market Challenges
    • Ethical issues associated with organ transplant

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplant Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplant Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplant Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplant Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplant Diagnostics Market

A detailed market share analysis in the Organ Transplant Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplant Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplant Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organ Transplant Diagnostics Market

A strategic analysis of the Organ Transplant Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BAG Diagnostics GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMAdvanced Diagnostics, Biomerieux SA., Bruker Corporation, CareDx Inc., F Hoffman La Roche Ltd., GenDx by Eurobio Scientific, Genome Diagnostics B.V., Hologic Inc., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Omixon Ltd., Oncocyte Corporation, Qiagen N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., SQI Diagnostics, Thermo Fisher Scientific Inc., TransMedics, Inc., and Werfen.

Market Segmentation & Coverage

This research report categorizes the Organ Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Technology, market is studied across Molecular Technologies and Non-Molecular Technologies.
  • Based on Application, market is studied across Diagnostic Applications and Research Applications.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of liver, kidney, and heart failure
      • 5.1.1.2. Government initiatives in promoting organ donation
      • 5.1.1.3. Rise of precision medicine to improve organ transplant diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations associated with diagnostics
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D to develop next generation organ transplant diagnostics
      • 5.1.3.2. Potential of medical tourism in organ transplantation
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues associated with organ transplant
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Organ Transplant Diagnostics Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. Organ Transplant Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Molecular Technologies
  • 7.3. Non-Molecular Technologies

8. Organ Transplant Diagnostics Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Applications
  • 8.3. Research Applications

9. Americas Organ Transplant Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Organ Transplant Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Organ Transplant Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BAG Diagnostics GmbH
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biogenuix Medsystems Pvt. Ltd
  • 6. BioMAdvanced Diagnostics
  • 7. Biomerieux SA.
  • 8. Bruker Corporation
  • 9. CareDx Inc.
  • 10. F Hoffman La Roche Ltd.
  • 11. GenDx by Eurobio Scientific
  • 12. Genome Diagnostics B.V.
  • 13. Hologic Inc.
  • 14. Illumina Inc.
  • 15. Laboratory Corporation of America Holdings
  • 16. Luminex Corporation
  • 17. Omixon Ltd.
  • 18. Oncocyte Corporation
  • 19. Qiagen N.V.
  • 20. Quest Diagnostics Incorporated
  • 21. Randox Laboratories Ltd.
  • 22. SQI Diagnostics
  • 23. Thermo Fisher Scientific Inc.
  • 24. TransMedics, Inc.
  • 25. Werfen

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023